February 19, 2024Canadian Medical Association Journal3 citationsOpen Access

Repetitive transcranial magnetic stimulation for smoking cessation

CIChristine Ibrahim VTVictor M. Tang DBDaniel M. Blumberger

Key Points

Key points are not available for this paper at this time.

Abstract

KEY POINTS In Canada, 10.3% of the population smokes tobacco.11 Each year, 8 million deaths worldwide are attributed to smoking.22 Currently, 3 pharmacotherapies are approved for smoking cessation in Canada: varenicline, bupropion, and nicotine replacement therapy (NRT). Although these

Ask AI

Helpful

Bookmark

View Full Paper

Cite This Study

Ibrahim et al. (Mon,) studied this question.

synapsesocial.com/papers/68e78961b6db6435876fb9eb https://doi.org/https://doi.org/10.1503/cmaj.230806

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials2015 · 111 citations
2Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial2016 · 1,183 citations
3Smoking Cessation Induced by Deep Repetitive Transcranial Magnetic Stimulation of the Prefrontal and Insular Cortices: A Prospective, Randomized Controlled Trial2014 · 374 citations
4Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials2013 · 612 citations
5Rate of inadvertently induced seizures with deep repetitive transcranial magnetic stimulation2018 · 26 citations

Ask AI

Helpful

Bookmark

View Full Paper